SIGN IN
Email Address
Password

Allergic Rhinitis: Practical Management for Improved Quality of Life—Strategies for Primary Care Clinicians



To start this activity, click "Begin" at the bottom of this page.

Allergic Rhinitis: Practical Management for Improved Quality of Life—Strategies for Primary Care Clinicians

Release Date:

March 31, 2012

Expiration Date:

July 31, 2013

Topics:

Allergic Disorders
Asthma / Rhinitis / COPD
Drug Information
Respiratory Medicine

Specialty:

Family Medicine / General Practice
Internal Medicine

Profession:

Nurse Practitioner
Physician
Physician Assistant

Format:

Monograph

Credits:

1.00 / AMA PRA Category 1 Credit(s)TM


Estimated Time to Complete:

1 hour

Program Description:

In evaluating patients with suspected allergic rhinitis (AR), knowing the allergens and obtaining an accurate diagnosis are essential in selecting appropriate treatment that is individualized to the patient, increases the likelihood of efficacy, and improves quality of life. The case study interwoven throughout this online monograph exemplifies how the common pitfalls of AR diagnosis and treatment can be avoided in your practice.

INTENDED AUDIENCE:

Primary care physicians, nurse practitioners, and physician assistants who care for allergy patients

Activity Objectives:

Upon completion of this educational activity, clinicians should be better able to:

  • Describe the prevalence, symptoms, and burden of illness of allergic rhinitis (AR).

  • Implement strategies to increase accurate identification of patients with AR.

  • Evaluate the benefits and limitations of current and emerging therapies for AR.

  • Provide patient education about effective management for AR


  • Credits Type Accreditation Statement Designation Statement
    1.00 AMA PRA Category 1 Credit(s)TM Albert Einstein College of Medicine of Yeshiva is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials. Albert Einstein College of Medicine of Yeshiva designates this enduring educational activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Each course participant should only claim credits commensurate with the extent of their participation in the activity.

    Faculty:

    CHAIR
    Warner W. Carr, MD, FAAAAI, FACAAI, FACP

    Associate Medical Director
    Allergy & Asthma Associates of Southern California
    Southern California Research
    Mission Viejo, California

    FACULTY
    Stuart W. Stoloff, MD, FAAAAI, FAAFP

    Clinical Professor
    Department of Family and Community Medicine
    University of Nevada School of Medicine
    Reno, Nevada

    CME COURSE REVIEWER
    David L. Rosenstreich, MD

    Professor, Department of Medicine (Allergy & Immunology)
    Albert Einstein College of Medicine of Yeshiva University
    Bronx, New York

    Click to Expand/Collapse Disclosures:

    Conflict of Interest Disclosure Statement
    The “Conflict of Interest Disclosure Policy” of Albert Einstein College of Medicine of Yeshiva University requires that faculty participating in any CME activity disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present.

    Warner W. Carr, MD, FAAAAI, FACAAI, FACP, has received grant/research from Meda Pharmaceuticals, Inc., Alcon Laboratories, Inc., and ISTA Pharmaceuticals, Inc. He is a consultant for Meda Pharmaceuticals, Inc., Alcon Laboratories, Inc., ISTA Pharmaceuticals, Inc., and Sunovion Pharmaceuticals Inc. Dr. Carr is also on the speakers’ bureaus for Meda Pharmaceuticals, Inc., Alcon Laboratories, Inc., ISTA Pharmaceuticals, Inc., GlaxoSmithKline, Merck & Co., Inc.

    Stuart W. Stoloff, MD, FAAAAI, FAAFP, is a consultant for Merck & Co., Inc., Teva Pharmaceuticals USA, Aerocrine, Sunovion Pharmaceuticals Inc., and AstraZeneca.

    David L. Rosenstreich, MD, has nothing to disclose with regard to commercial support.

    Publishing Staff
    Mary Jo Krey, Eileen McCaffrey
    , and Sharon Hill-Ingram of Haymarket Medical Education have nothing to disclose with regard to commercial support.

    Accreditor Staff
    The staff of the Center for Continuing Medical Education of Albert Einstein College of Medicine of Yeshiva University has nothing to disclose with regard to commercial support.

    Disclosure of Unlabeled Use
    This educational activity may contain discussion of approved and/or investigational uses of agents that are not indicated by the FDA. Albert Einstein College of Medicine of Yeshiva University, Meda Pharmaceuticals, Inc., and Haymarket Medical Education do not recommend the use of any agent outside of the labeled indications.

    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Albert Einstein College of Medicine of Yeshiva University, Meda Pharmaceuticals, Inc., and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Disclaimer
    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

    Privacy Policy
    To view the myCME privacy policy, please click here.

    To view the privacy policy for Albert Einstein College of Medicine of Yeshiva University, please click here.

    Accredited Provider:

    This program is sponsored by Albert Einstein College of Medicine of Yeshiva University.

    Commercial Supporter:

    This program is supported by an educational grant from Meda Pharmaceuticals, Inc.

    Instructions:

    To obtain credit, a score of 70% or better is required. This CE is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the posttest survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.

    If you have any questions relating to the accreditation of this activity, please contact Mildred Shields Adighiuzor, Associate Director, Albert Einstein College of Medicine, CME Marketing at (718) 920-6674.

    If you have any questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.

    Click to Expand/Collapse SYSTEM REQUIREMENTS:

    WINDOWS PC SYSTEM REQUIREMENTS:
    266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.

    MACINTOSH® SYSTEM REQUIREMENTS:
    Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20 MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands of Colors”; Macromedia Flash Player 6 or higher.



Home | Browse By Disease | Browse By Specialty | Browse By Profession | About HME | Contact Us | Web Support

© 2013 Haymarket Media, Inc.

Your use of this website constitutes acceptance of Haymarket Medical Education's Privacy Policy and Terms & Conditions

Haymarket Medical Education